Futura Medical (FUM)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

35.65p
   
  • Change Today:
      0.15p
  • 52 Week High: 65.00
  • 52 Week Low: 25.50
  • Currency: UK Pounds
  • Shares Issued: 301.45m
  • Volume: 425,659
  • Market Cap: £107.47m
  • RiskGrade: 479

Income Statement - Normalised

  £ (Millions) £ (Millions) £ (Millions)
31-Dec-10 31-Dec-09 31-Dec-08
Continuing Operations      
Revenue 0.12 0.05 0.15
       
EBITDA (1.33) (1.51) (2.16)
Depreciation & Amortisation (0.01) (0.01) (0.02)
       
Operating Profit/(Loss) (1.34) (1.53) (2.17)
Interest Payable n/a n/a n/a
Interest Receivable/Investment Income 0.02 0.01 0.10
       
Group Profit after Interest (1.32) (1.51) (2.08)
Share of Assoc Cos/JV Profits n/a n/a n/a
       
Profit Before Tax (1.32) (1.51) (2.08)
Tax 0.23 0.12 0.14
       
Profit After Tax (1.09) (1.39) (1.94)
       
Discontinued Operations      
Profit After Tax n/a n/a n/a
       
PROFIT FOR PERIOD (1.09) (1.39) (1.93)
       
Attributable to:      
Equity Holders of Parent Company (1.09) (1.39) (1.93)
Minority Interests n/a n/a n/a
       
Equity Dividends cn/a cn/a cn/a
Retained Profit/(Loss) for the Financial Year c(1.09) c(1.39) c(1.93)


Per Share Record - Normalised 31-Dec-10 31-Dec-09 31-Dec-08
Continuing EPS      
Earnings per Share - Basic (1.61p) (2.24p) (3.36p)
Earnings per Share - Diluted (1.61p) (2.24p) (3.36p)
Earnings per Share - Adjusted (1.60p) (2.23p) (3.34p)
Continuing and Discontinued EPS      
Earnings per Share - Basic (1.61p) (2.24p) (3.36p)
Earnings per Share - Diluted (1.61p) (2.24p) (3.36p)
Earnings per Share - Adjusted (1.60p) (2.23p) (3.34p)
       
Dividend per Share n/a n/a n/a


Key Financals 31-Dec-10 31-Dec-09 31-Dec-08
Shares in Issue (millions)      
Shares in Issue - Year End 67.64 67.48 57.62
Weighted Average 67.56 62.22 57.62
Diluted 67.56 62.22 57.62
       
Performance Ratios      
Continuing Operations      
Operating Margin (1,069.60%) (3,052.00%) (1,449.33%)
Return on Capital Employed n/a n/a n/a
Continuing Operations & Discontinued Operations      
Return on Equity (121.15%) (75.18%) (218.31%)
       
Financial Status      
Continuing Operations      
Interest Cover - Continuing n/a n/a n/a
Revenue per Share 0.18p 0.080p 0.26p
Pre-Tax Profit Per Share - Continuing (1.95p) (2.43p) (3.61p)
       
Market Data      
Continuing Operations      
Earnings Per Share Growth - Basic n/a n/a n/a
Earnings Per Share Growth - Diluted n/a n/a n/a
PE Ratio - Company Adjusted n/a n/a n/a
PEG - Company Adjusted n/a n/a n/a
Dividend Cover n/a n/a n/a
Continuing Operations & Discontinued Operations      
Earnings per Share - Company Adjusted n/a n/a n/a
Earnings per Share - Diluted n/a n/a n/a
PE Ratio - Company Adjusted n/a n/a n/a
PEG - Company Adjusted n/a n/a n/a
Dividend Cover n/a n/a n/a
       
Market Capitalisation £ (Millions) 48.09 25.16 17.33
Dividend per Share n/a n/a n/a
Dividend Yield 0.0% 0.0% 0.0%
Dividend per Share Growth n/a n/a n/a

Key

* GAAP

a. Includes discontinued activities

b. Includes preference dividends

c. Not disclosed under IFRS

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: Forecast figures based on normalised accounts.

 

Top of Page